MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
1) Consolidators: Life Science & Therapeutics Sector
*Consolidators: Therapeutics Sector
*Consolidators: Diabetes and Kidney Health Companies
Embecta Corp. (NASDAQ: EMBC)*
Organization & Developments: Embecta
Parents
Embecta Corp. (NASDAQ: EMBC)*
Children
*Embecta has deep expertise and advanced technologies to continuously innovate pen needles, insulin syringes and other products
*Embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes
2022: BD Announces Completion of Embecta Corp. Spinoff
2022: Embecta: Comments On 2nd Earnings Since Spin Off_seekingalpha.com
2022: Embecta: Market Bullish Into Q4 Earnings, We'd Like More Evidence_ seekingalpha.com
2023: Embattled Embecta Continues To Present Challenges To Shareholder Value (NASDAQ:EMBC)
2023: Embecta: Mammoth Effort Needed To Get Investors Over The Line, Reiterate Hold
2024: Embecta Corp.: Navigating Through A Changing Landscape
2024: Embecta shutters newly cleared insulin patch pump program amid layoffs, restructuring
2024: Embecta to lay off 118 in Massachusetts
2024: New Initiatives Expected To Make Embecta More Profitable
2025: Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply
2025: Upgrading Embecta Due To Reorganization And Growth Initiatives
Jumps
Finance & Acquisitions: Embecta
Key People: Embecta